Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Melanoma is the most fatal skin cancer, but the etiology of this devastating disease is still poorly understood. Recently, the transcription factor Sox10 has been shown to promote both melanoma initiation and progression. Reducing SOX10 expression levels in human melanoma cells and in a genetic melanoma mouse model, efficiently abolishes tumorigenesis by inducing cell cycle exit and apoptosis. Here, we show that this anti-tumorigenic effect functionally involves SOX9, a factor related to SOX10 and upregulated in melanoma cells upon loss of SOX10. Unlike SOX10, SOX9 is not required for normal melanocyte stem cell function, the formation of hyperplastic lesions, and melanoma initiation. To the contrary, SOX9 overexpression results in cell cycle arrest, apoptosis, and a gene expression profile shared by melanoma cells with reduced SOX10 expression. Moreover, SOX9 binds to the SOX10 promoter and induces downregulation of SOX10 expression, revealing a feedback loop reinforcing the SOX10 low/SOX9 high ant,m/ii-tumorigenic program. Finally, SOX9 is required in vitro and in vivo for the anti-tumorigenic effect achieved by reducing SOX10 expression. Thus, SOX10 and SOX9 are functionally antagonistic regulators of melanoma development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“we found amongst our top SALL4-HDAC2 shared de novo DNA binding motifs matches for known transcriptional regulators of the NC that are re-expressed and have functional implication in melanoma, such as SOX10 and SOX948 or RUNX149,50, and also key regulators of melanocyte differentiation and hence melanoma, such as MITF51 or TFAP2C52,53”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“This is reminiscent of melanoma cells displaying reduced SOX10 levels, which is associated with increased expression of SOX9, another factor involved in NC development, and increased invasiveness48,71.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
SOX9 directly regulates the type-ll collagen gene
Bell, D. M., Leung, K. K. H., Wheatley, S. C., Ng, L. J., Zhou, S., Wing Ling, K., Har Sham, M., Koopman, P., Tam, P. P. L., & Cheah, K. S. E. (1997) · Nature Genetics · doi:10.1038/ng0697-174 · Cited by 933 · cited 1×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundThe Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate
Sarkar, A., & Hochedlinger, K. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.007 · Cited by 920 · cited 1×
“Sox genes play key roles in embryonic development and are major determinants of stem cell behavior, regulating cell fate decisions and maintaining cellular identity [3].”
BackgroundThe transcription factor Sox10 is a key regulator of peripheral glial development
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K.-A., Birchmeier, C., & Wegner, M. (2001) · Genes & Development · doi:10.1101/gad.186601 · Cited by 914 · cited 2×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundSelf-citationDominant role of the niche in melanocyte stem-cell fate determination
Nishimura, E. K., Jordan, S. A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I. J., Barrandon, Y., Miyachi, Y., & Nishikawa, S.-I. (2002) · Nature · doi:10.1038/416854a · Cited by 901 · cited 1×
“Melanocyte stem cells are found in a specialized region of the hair follicle called bulge and give rise to melanocyte progenitors and differentiated melanocytes [42].”
BackgroundFrom head to toes: the multiple facets of Sox proteins
Wegner, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1409 · Cited by 890 · cited 1×
“A common feature of SoxE group proteins, which includes Sox9 and Sox10, is their expression in neural crest (NC) cells during embryonic development [2, 11].”
BackgroundSelf-citationSOX10 mutations in patients with Waardenburg-Hirschsprung disease
Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D. E., Préhu, M.-O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-171 · Cited by 825
Self-citationda Silva, S. M., Hacker, A., Harley, V., Goodfellow, P., Swain, A., & Lovell-Badge, R. (1996) · Nature Genetics · doi:10.1038/ng0996-62 · Cited by 795
Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche
Nishimura, E. K., Granter, S. R., & Fisher, D. E. (2005) · Science · doi:10.1126/science.1099593 · Cited by 750 · cited 1×
“When melanocyte stem cells are functionally impaired, they fail to generate melanocytes, which results in hair graying [43].”
BackgroundIn vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743
Self-citationA male-specific role for SOX9 in vertebrate sex determination
Kent, J., Wheatley, S. C., Andrews, J. E., Sinclair, A. H., & Koopman, P. (1996) · Development · doi:10.1242/dev.122.9.2813 · Cited by 710
SOX10 Maintains Multipotency and Inhibits Neuronal Differentiation of Neural Crest Stem Cells
Kim, J., Lo, L., Dormand, E., & Anderson, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00163-6 · Cited by 581
Hair follicle stem cells are specified and function in early skin morphogenesis
Nowak, J. A., Polak, L., Pasolli, H. A., & Fuchs, E. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.009 · Cited by 554 · cited 4×
“), in agreement with previous reports [37,38,45].”
ResultInfluentialNeural crest development is regulated by the transcription factor Sox9
Cheung, M., & Briscoe, J. (2003) · Development · doi:10.1242/dev.00808 · Cited by 482 · cited 2×
“Similarly, in avian and Xenopus embryos, Sox9 and Sox10 are co-expressed in premigratory neural crest cells and are both able to induce ectopic neural crest cell formation upon forced expression in chicken neural tube [11,24,54].”
BackgroundMitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage
Goding, C. R. (2000) · Genes & Development · doi:10.1101/gad.14.14.1712 · Cited by 471 · cited 1×
“Double immunostaining for SOX9 and MITF (Microphthalmia-associated transcription factor), an established marker of melanocytes [39] revealed no detectable SOX9 expression in human skin melanocytes in vivo (Fig.”
BackgroundLefebvre, V., Dumitriu, B., Penzo-Méndez, A., Han, Y., & Pallavi, B. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.05.019 · Cited by 467 · cited 1×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundThe transcriptional control of trunk neural crest induction, survival, and delamination
Cheung, M., Chaboissier, M.-C., Mynett, A., Hirst, E., Schedl, A., & Briscoe, J. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.12.010 · Cited by 427 · cited 2×
“Similarly, in avian and Xenopus embryos, Sox9 and Sox10 are co-expressed in premigratory neural crest cells and are both able to induce ectopic neural crest cell formation upon forced expression in chicken neural tube [11,24,54].”
Vidal, V. P. I., Chaboissier, M.-C., Lützkendorf, S., Cotsarelis, G., Mill, P., Hui, C.-C., Ortonne, N., Ortonne, J.-P., & Schedl, A. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.064 · Cited by 427 · cited 2×
“), in agreement with previous reports [37,38,45].”
ResultSox10: A Pan-Schwannian and Melanocytic Marker
Nonaka, D., Chiriboga, L., & Rubin, B. P. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181658c14 · Cited by 405
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans-Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M., & Wegner, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5161 · Cited by 370
Self-citationParatore, C., Goerich, D. E., Suter, U., Wegner, M., & Sommer, L. (2001) · Development · doi:10.1242/dev.128.20.3949 · Cited by 338
Self-citationMackenzie, M. A. F., Jordan, S. A., Budd, P. S., & Jackson, I. J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8738 · Cited by 331 · cited 1×
“Dct-LacZ mice were described previously [44].”
Uchikawa, M., Kamachi, Y., & Kondoh, H. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00083-0 · Cited by 329
Ackermann, J., Frutschi, M., Kaloulis, K., McKee, T., Trumpp, A., & Beermann, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2970 · Cited by 306 · cited 2×
“Mice Tyr::Nras [48] were provided by F.”
MethodMatching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators
Wilson, M., & Koopman, P. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00323-4 · Cited by 306
The transcription factor Sox9 is required for cranial neural crest development in Xenopus
Spokony, R. F., Aoki, Y., Saint-Germain, N., Magner-Fink, E., & Saint-Jeannet, J.-P. (2002) · Development · doi:10.1242/dev.129.2.421 · Cited by 295
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293
Self-citationSox10 promotes the formation and maintenance of giant congenital naevi and melanoma
Shakhova, O., Zingg, D., Schaefer, S. M., Hari, L., Civenni, G., Blunschi, J., Claudinot, S., Okoniewski, M., Beermann, F., Mihic-Probst, D., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2535 · Cited by 274 · cited 10×
“While SOX10 expression and function has been well established in adult melanocytes, naevi, and melanoma tissue in human and mice [9; 23], studies on SOX9 expression in melanocytic cells are controversial.”
BackgroundMethodResultSelf-citationSox10 regulates the development of neural crest-derived melanocytes in Xenopus
Aoki, Y., Saint-Germain, N., Gyda, M., Magner-Fink, E., Lee, Y.-H., Credidio, C., & Saint-Jeannet, J.-P. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00161-1 · Cited by 270 · cited 4×
“Studies in Xenopus embryos demonstrated that while expression of Sox10 at the two-cell stage was sufficient to activate the expression of Trp-2 (Dct) and the induction of melanocytic precursors, the expression of Sox9 failed to do so [24].”
BackgroundInfluentialDeletions at the SOX10 Gene Locus Cause Waardenburg Syndrome Types 2 and 4
Bondurand, N., Dastot-Le Moal, F., Stanchina, L., Collot, N., Baral, V., Marlin, S., Attie-Bitach, T., Giurgea, I., Skopinski, L., Reardon, W., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522090 · Cited by 261
A clinical and genetic study of campomelic dysplasia.
Mansour, S., Hall, C. M., Pembrey, M. E., & Young, I. D. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.6.415 · Cited by 253 · cited 1×
“Finally, in agreement with our expression studies on human skin, humans carrying mutations in SOX9 display campomelic dysplasia affecting the skeleton and reproductive system but not melanocytes, whereas patients with mutations in SOX10 often exhibit pigmentary anomalies [20,50,59].”
ResultSox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage
Finzsch, M., Schreiner, S., Kichko, T., Reeh, P., Tamm, E. R., Bösl, M. R., Meijer, D., & Wegner, M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200912142 · Cited by 243 · cited 2×
“Sox10 mice were described previously [47].”
MethodSelf-citationSox10 is required for the early development of the prospective neural crest in Xenopus embryos
Honoré, S. M., Aybar, M. J., & Mayor, R. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00247-1 · Cited by 241 · cited 1×
“Interfering with Sox10 function leads to inhibition of Sox9 expression [55], suggesting that Sox10 is required for the expression of Sox9 in pre-migratory neural crest.”
BackgroundFinzsch, M., Stolt, C. C., Lommes, P., & Wegner, M. (2008) · Development · doi:10.1242/dev.010454 · Cited by 235
Self-citationMollaaghababa, R., & Pavan, W. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206442 · Cited by 222
Vervoort, S. J., van Boxtel, R., & Coffer, P. J. (2013) · Oncogene · doi:10.1038/onc.2012.506 · Cited by 198
Potterf, S. B., Mollaaghababa, R., Hou, L., Southard-Smith, E. M., Hornyak, T. J., Arnheiter, H., & Pavan, W. J. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0372 · Cited by 169
Characterization of melanocyte‐specific inducible Cre recombinase transgenic mice
Bosenberg, M., Muthusamy, V., Curley, D. P., Wang, Z., Hobbs, C., Nelson, B., Nogueira, C., Horner, J. W., DePinho, R., & Chin, L. (2006) · genesis · doi:10.1002/dvg.20205 · Cited by 160 · cited 2×
“Tyr-CreERT2 line [46] was provided by L.”
MethodSoxE function in vertebrate nervous system development
Stolt, C. C., & Wegner, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.014 · Cited by 159 · cited 2×
“Finally, in agreement with our expression studies on human skin, humans carrying mutations in SOX9 display campomelic dysplasia affecting the skeleton and reproductive system but not melanocytes, whereas patients with mutations in SOX10 often exhibit pigmentary anomalies [20,50,59].”
BackgroundResultSelf-citationParatore, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3075 · Cited by 155
SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation
Passeron, T., Valencia, J. C., Bertolotto, C., Hoashi, T., Le Pape, E., Takahashi, K., Ballotti, R., & Hearing, V. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705117104 · Cited by 147 · cited 1×
“Likewise, apart from experimentally reducing SOX10 levels, other stimuli such as UV exposure might also lead to upregulation of SOX9 [51].”
BackgroundFunctional Analysis of Sox10 Mutations Found in Human Waardenburg-Hirschsprung Patients
Kuhlbrodt, K., Schmidt, C., Sock, E., Pingault, V., Bondurand, N., Goossens, M., & Wegner, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23033 · Cited by 139
Self-citationPasseron, T., Valencia, J. C., Namiki, T., Vieira, W. D., Passeron, H., Miyamura, Y., & Hearing, V. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci34015 · Cited by 116 · cited 1×
“revealed that overexpression of SOX9 prevents melanoma formation [35] by increasing the expression of the CDK inhibitor p21 and subsequent cell cycle arrest.”
BackgroundConditional inactivation of Sox9: A mouse model for campomelic dysplasia
Kist, R., Schrewe, H., Balling, R., & Scherer, G. (2002) · genesis · doi:10.1002/gene.10050 · Cited by 111 · cited 2×
“Sox9 mice [27] were a kind gift from G.”
BackgroundMethodStolt, C. C., Schmitt, S., Lommes, P., Sock, E., & Wegner, M. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.03.010 · Cited by 111 · cited 1×
“For instance, in oligodendroglial progenitors, concomitant expression of Sox9 can compensate for the loss of Sox10 [52,53].”
BackgroundSelf-citationHarris, M. L., Buac, K., Shakhova, O., Hakami, R. M., Wegner, M., Sommer, L., & Pavan, W. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003644 · Cited by 110 · cited 3×
“Mice lacking Sox10 in the melanocyte lineage display hair graying, indicating that Sox10 is necessary for maintenance of melanocyte stem cells and committed melanoblasts [23] (Fig.”
BackgroundSelf-citationConsistent expression of the stem cell renewal factor BMI‐1 in primary and metastatic melanoma
Mihic‐Probst, D., Kuster, A., Kilgus, S., Bode‐Lesniewska, B., Ingold‐Heppner, B., Leung, C., Storz, M., Seifert, B., Marino, S., Schraml, P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22891 · Cited by 107 · cited 1×
“TMA containing melanoma tissue was constructed as previously described [61].”
MethodSelf-citationSOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis
Cronin, J. C., Watkins-Chow, D. E., Incao, A., Hasskamp, J. H., Schönewolf, N., Aoude, L. G., Hayward, N. K., Bastian, B. C., Dummer, R., Loftus, S. K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4620 · Cited by 104
Self-citationThe transcription factor Sox5 modulates Sox10 function during melanocyte development
Stolt, C. C., Lommes, P., Hillgartner, S., & Wegner, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn527 · Cited by 93 · cited 3×
“In particular, Sox10 but not Sox9 is expressed in and required for the generation of melanoblasts during mouse embryogenesis [13, 21].”
BackgroundResultSelf-citationSOX9 expression is a general marker of basal cell carcinoma and adnexal‐related neoplasms
Vidal, V. P. I., Ortonne, N., & Schedl, A. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00815.x · Cited by 91
Castillo, S. D., Matheu, A., Mariani, N., Carretero, J., López‐Ríos, F., Lovell-Badge, R. H., & Sánchez‐Céspedes, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-3506 · Cited by 85
SoxE Proteins Are Differentially Required in Mouse Adrenal Gland Development
Reiprich, S., Stolt, C. C., Schreiner, S., Parlato, R., & Wegner, M. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-08-0782 · Cited by 80
Self-citationNestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma
Bakos, R. M., Maier, T., Besch, R., Mestel, D. S., Ruzicka, T., Sturm, R. A., & Berking, C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00991.x · Cited by 76
Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro
Cook, A. L., Smith, A. G., Smit, D. J., Leonard, J. H., & Sturm, R. A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.019 · Cited by 73 · cited 2×
“Interestingly, an inverse correlation between SOX10 and SOX9 expression has previously been observed in several systems, including cultured human melanocytes, where upon the induction of differentiation, SOX10 levels were reduced concomitantly with an increase in SOX9 levels [32].”
BackgroundFantauzzo, K. A., Kurban, M., Levy, B., & Christiano, A. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003002 · Cited by 72 · cited 1×
“), in agreement with previous reports [37,38,45].”
Neural crest-derived stem cells
Sommer, L. (2010) · StemBook · doi:10.3824/stembook.1.51.1 · Cited by 71 · cited 1×
“NC cells are a transient embryonic cell population that gives rise to most of the peripheral nervous system, chondrocytes and osteoblasts of craniofacial structures, smooth muscle cells of the cardiovascular system, and melanocytes, the pigmented cells of the skin [12].”
BackgroundSelf-citationJohn, N., Cinelli, P., Wegner, M., & Sommer, L. (2011) · Stem Cells · doi:10.1002/stem.607 · Cited by 67
Self-citationSumoylation of the SOX10 transcription factor regulates its transcriptional activity
Girard, M., & Goossens, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.011 · Cited by 65
SOX9 and SOX10 but Not BRN2 Are Required for Nestin Expression in Human Melanoma Cells
Flammiger, A., Besch, R., Cook, A. L., Maier, T., Sturm, R. A., & Berking, C. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.316 · Cited by 61
SUMOylated SoxE factors recruit Grg4 and function as transcriptional repressors in the neural crest
Lee, P., Taylor, K. M., Nordin, K., Prasad, M. S., Lander, R. M., & LaBonne, C. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201204161 · Cited by 57
Analysis of Chromatin Composition of Repetitive Sequences: The ChIP-Chop Assay
Santoro, R. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-706-8_25 · Cited by 23 · cited 1×
“ChIP analysis was performed as previously described [62].”
MethodSelf-citationKrahl, D., & Sellheyer, K. (2009) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01369.x · Cited by 20 · cited 2×
“In contrast, murine Sox9 appeared not to be expressed in melanocytic cells of the normal skin, nevi, and primary melanoma, while it was readily detectable in epithelial cells in accordance with previous reports [33,37,38].”
BackgroundResult
Cited by
The role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
Wouters, J., Kalender-Atak, Z., Minnoye, L., Spanier, K. I., De Waegeneer, M., Bravo González-Blas, C., Mauduit, D., Davie, K., Hulselmans, G., Najem, A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0547-3 · Cited by 258
Epithelial‐to‐mesenchymal‐like transition events in melanoma
Pedri, D., Karras, P., Landeloos, E., Marine, J., & Rambow, F. (2022) · The FEBS Journal · doi:10.1111/febs.16021 · Cited by 126
Epigenetics of malignant melanoma
Moran, B., Silva, R., Perry, A. S., & Gallagher, W. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.006 · Cited by 142
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Capparelli, C., Purwin, T. J., Glasheen, M. Q., Caksa, S., Tiago, M., Wilski, N. A., Pomante, D., Rosenbaum, S. R., Nguyen, M. Q., Cai, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28801-y · Cited by 109
Metadata
- Authors
- Shakhova, O., Cheng, P., Mishra, P. J., Zingg, D., Schaefer, S. M., Debbache, J., Häusel, J., Matter, C., Guo, T., Davis, S., Meltzer, P., Mihic-Probst, D., Moch, H., Wegner, M., Merlino, G., Levesque, M. P., Dummer, R., Santoro, R., Cinelli, P., & Sommer, L.
- Affiliations
- University of Zurich (CH)
- University Hospital Zurich (CH)
- National Institutes of Health (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Sommer, Lukas
- ORCID
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-01-28
- Volume
- 11
- Issue
- 1
- Pages
- e1004877
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4309598
- OpenAlex
- W2052814985
- Cited by
- 111
- References
- 63
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 7 · 2017: 11 · 2016: 15 · 2015: 3
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Genetics (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, public-domain)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
- Promedica Stiftung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melanoma, SOX9, SOX10, transcription factor antagonism, cross-regulation, cell cycle arrest, apoptosis, melanocyte stem cells, feedback loops, tumor suppression
- MeSH terms
- Animals, Humans, Melanocytes, Melanoma, Gene Expression Regulation, Neoplastic, Apoptosis, Hair Follicle, RNA, Small Interfering, Cell Line, Tumor, Mice, SOXE Transcription Factors, SOX9 Transcription Factor, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.